Idera to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 09 2015 - 1:00PM
Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage
biopharmaceutical company developing toll-like receptor and RNA
therapeutics for patients with cancer and rare diseases, today
announced that Vincent Milano, Idera's Chief Executive Officer will
present a corporate update at the 33rd Annual J.P. Morgan
Healthcare Conference on Thursday, January 15, 2015 at 10:30 a.m.
Pacific Time / 1:30 p.m. Eastern Time at the Westin St. Francis
Hotel in San Francisco. The presentation will be followed by a
question and answer session that will begin at 11:00 a.m. Pacific
Time / 2:00 p.m. Eastern Time.
A live audio webcast of Idera's presentation and the question
and answer session will be accessible in the Investors and Media
section of Idera's website at http://www.iderapharma.com. An
archived version will also be available on the Company's website
after the event for 90 days.
Also, as a convenience to investors the company will post a copy
of the latest corporate slide presentation in the Investors and
media section of the Idera website on Monday, January 12, 2015 at
7:00 a.m. Eastern Time.
About Idera Pharmaceuticals
Idera Pharmaceuticals is a clinical-stage patient focused
biopharmaceutical company developing novel therapeutic approaches
for the treatment of cancer and rare diseases. Idera's proprietary
technology involves creating novel nucleic acid therapeutics.
Idera's immunotherapy approach is based on the modulation of
Toll-like receptors (TLRs). In addition to its TLR modulation
programs, Idera is developing gene silencing oligonucleotides (GSO)
technology that it has created to inhibit the production of
disease-associated proteins by targeting RNA. To learn more about
Idera, visit www.iderapharma.com.
CONTACT: Investor and Media Contact
Robert Doody
Vice President, Investor Relations and
Corporate Communications
484-639-7235
rdoody@iderapharma.com
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Apr 2023 to Apr 2024